JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 6 1043-1048
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wartski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wartski, M.

Incomplete Recovery of Lung Perfusion After 3 Months in Patients with Acute Pulmonary Embolism Treated with Antithrombotic Agents

Myriam Wartski, Marie-Anne Collignon for the THESEE Study Group

Department of Nuclear Medicine, Marie Lannelongue Surgical Center, Le Plessis-Robinson
Department of Nuclear Medicine, Laennec Hospital, Paris, France

Correspondence: For correspondence or reprints contact: Myriam Wartski, MD, Department of Nuclear Medicine, Marie Lannelongue Surgical Center, 133 avenue de la Resistance, 92 350 Le Plessis-Robinson, France.

ABSTRACT

We assessed the time course of lung perfusion after 3 mo of anticoagulant therapy for acute pulmonary embolism (APE) on the basis of perfusion lung scan (PLS) findings for 157 patients included in the Tinzaparin ou Heparin Standard: Evaluation dans I'Embolie Pulmonaire Study (THESEE), a multicenter, randomized, nonmasked trial comparing standard, continuous, adjusted-dose intravenous heparin with once-daily, subcutaneous, low-molecular-weight heparin in patients with APE. Methods: We calculated the percentage-of-vascular-obstruction score (PVOs) on PLSs on the day of diagnosis of APE (PVOsD1), on day 8 (PVOsD8), and after 3 mo (PVOsM3) and the mean relative changes in PVOs on day 8 versus the day of diagnosis and after 3 mo versus the day of diagnosis. Results: Mean PVOsD1 ± SD was 49% ± 20%, PVOsD8 was 29% ± 18%, and PVOsM3 was 19% ± 18%. PVOsDI was at least 50% in 49% of patients. Reperfusion did not correlate with age, importance of initial obstruction, or clinical severity of disease at inclusion in THESEE. Relative change after 3 mo versus at diagnosis was lower in the 87 patients with associated prior cardiopulmonary disease than in those without. In the 43 patients with a history of thromboem-bolic disease, neither mean PVOsD1 nor the time course of PVOs was different from those in patients without a history of thromboembolic disease. Residual defects after 3 mo were observed in 104 patients (66%), including 13 with a PVOs of at least 50%. Conclusion: These results emphasize the need for a control PLS at completion of anticoagulant therapy for APE, even in patients with full resolution of symptoms.

Key Words: acute pulmonary embolism • perfusion lung scan • residual perfusion defects




This article has been cited by other articles:


Home page
JNMHome page
L. M. Freeman
Don't Bury the V/Q Scan: It's as Good as Multidetector CT Angiograms with a Lot Less Radiation Exposure
J. Nucl. Med., January 1, 2008; 49(1): 5 - 8.
[Full Text] [PDF]


Home page
HeartHome page
K. McNeil and J. Dunning
Chronic thromboembolic pulmonary hypertension (CTEPH)
Heart, September 1, 2007; 93(9): 1152 - 1158.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
V. F. Tapson and M. Humbert
Incidence and Prevalence of Chronic Thromboembolic Pulmonary Hypertension: From Acute to Chronic Pulmonary Embolism
Proceedings of the ATS, September 1, 2006; 3(7): 564 - 567.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses
Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Nijkeuter, M. M.C. Hovens, B. L. Davidson, and M. V. Huisman
Resolution of Thromboemboli in Patients With Acute Pulmonary Embolism: A Systematic Review
Chest, January 1, 2006; 129(1): 192 - 197.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Dartevelle, E. Fadel, S. Mussot, A. Chapelier, P. Herve, M. de Perrot, J. Cerrina, F.L. Ladurie, D. Lehouerou, M. Humbert, et al.
Chronic thromboembolic pulmonary hypertension
Eur. Respir. J., April 1, 2004; 23(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. F. Fedullo and V. F. Tapson
The Evaluation of Suspected Pulmonary Embolism
N. Engl. J. Med., September 25, 2003; 349(13): 1247 - 1256.
[Full Text] [PDF]


Home page
JNMHome page
M. A. Meignan
Lung Ventilation/Perfusion SPECT: The Right Technique for Hard Times
J. Nucl. Med., May 1, 2002; 43(5): 648 - 651.
[Full Text] [PDF]


Home page
NEJMHome page
P. F. Fedullo, W. R. Auger, K. M. Kerr, and L. J. Rubin
Chronic Thromboembolic Pulmonary Hypertension
N. Engl. J. Med., November 15, 2001; 345(20): 1465 - 1472.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. GIRARD, M. DECOUSUS, S. LAPORTE, A. BUCHMULLER, P. HERVE, C. LAMER, F. PARENT, and B. TARDY
Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis . Specificity of Symptoms and Perfusion Defects at Baseline and during Anticoagulant Therapy
Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1033 - 1037.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.